271 related articles for article (PubMed ID: 34951997)
41. Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Lin FY; Hsieh YH; Yang SF; Chen CT; Tang CH; Chou MY; Chuang YT; Lin CW; Chen MK
J Oral Pathol Med; 2015 Oct; 44(9):699-706. PubMed ID: 25401496
[TBL] [Abstract][Full Text] [Related]
42. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
43. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
44. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
45. BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.
Chou CK; Wu CY; Chen JY; Ng MC; Wang HM; Chen JH; Yuan SS; Tsai EM; Chang JG; Chiu CC
Int J Mol Sci; 2015 Jul; 16(7):15104-17. PubMed ID: 26151845
[TBL] [Abstract][Full Text] [Related]
46. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma.
Liu Z; Tao H
J Cell Biochem; 2020 Mar; 121(3):2150-2158. PubMed ID: 31762107
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma.
Zhang H; Jiang S; Guo L; Li X
J Cell Mol Med; 2019 Apr; 23(4):2813-2821. PubMed ID: 30734471
[TBL] [Abstract][Full Text] [Related]
48. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
49. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1.
Oku N; Sasabe E; Ueta E; Yamamoto T; Osaki T
Cancer Res; 2006 May; 66(10):5251-7. PubMed ID: 16707450
[TBL] [Abstract][Full Text] [Related]
50. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation.
Kurihara Y; Hatori M; Ando Y; Ito D; Toyoshima T; Tanaka M; Shintani S
Clin Exp Metastasis; 2009; 26(5):425-32. PubMed ID: 19241124
[TBL] [Abstract][Full Text] [Related]
52. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5.
Wang L; Chen W; Zha J; Yan Y; Wei Y; Chen X; Zhu X; Ge L
Oncol Rep; 2019 Sep; 42(3):973-990. PubMed ID: 31322243
[TBL] [Abstract][Full Text] [Related]
53. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation.
Yu Q; Du Y; Wang S; Zheng X
J Biochem; 2021 Sep; 169(6):721-730. PubMed ID: 33725092
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract][Full Text] [Related]
56. MMP-11 promoted the oral cancer migration and Fak/Src activation.
Hsin CH; Chou YE; Yang SF; Su SC; Chuang YT; Lin SH; Lin CW
Oncotarget; 2017 May; 8(20):32783-32793. PubMed ID: 28427180
[TBL] [Abstract][Full Text] [Related]
57. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
[TBL] [Abstract][Full Text] [Related]
58. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
59. Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
Yang L; Song X; Zhu J; Li M; Ji Y; Wu F; Chen Y; Cui X; Hu J; Wang L; Cao Y; Wei Y; Zhang W; Li F
Int J Oncol; 2017 Jul; 51(1):378-388. PubMed ID: 28534990
[TBL] [Abstract][Full Text] [Related]
60. Modulation of cell growth and matrix metalloproteinase-2 activation of oral squamous cell carcinoma as a function of culture condition with type I collagen.
Kinsenn H; Sato H; Furukawa M; Yoshizaki T
Acta Otolaryngol; 2003 Oct; 123(8):987-93. PubMed ID: 14606604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
